TLX
Telix Pharmaceuticals Ltd
Telix Pharmaceuticals Ltd insider trading
Telix Pharmaceuticals Ltd is on this site because an insider bought its stock on the open market in the last 30 days. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.
From SEC filings · last 30 days
Recent TLX insider transactions
The filing store could not be read just now — this page tries again on its next refresh. The filings themselves are on SEC EDGAR.
SEC Form 4 data, Q3 2024 to Q2 2026
TLX insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, one insider traded TLX on the open market: 2 purchases worth $996.7K and 0 sales. In the last four quarters alone: 2 purchases ($996.7K) and 0 sales, by one insider.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | +$996.7K2 buys | — | |
| Q1 2026 | — | — | |
| Q4 2025 | — | — | |
| Q3 2025 | — | — | |
| Q2 2025 | — | — | |
| Q1 2025 | — | — | |
| Q4 2024 | — | — | |
| Q3 2024 | — | — |
- Largest purchase
- +$499.6K of TLX by Behrenbruch Christian (MD & Group CEO · Director) on Apr 28, 2026.
Open-market transactions through Jun 30, 2026most recent first
Behrenbruch Christian
MD & Group CEO · Director
+$497.2K
Apr 29, 2026
33,435 sh · $14.87
Behrenbruch Christian
MD & Group CEO · Director
+$499.6K
Apr 28, 2026
34,500 sh · $14.48
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Apr 29, 2026 | Behrenbruch ChristianMD & Group CEO · Director | 33,435 | $14.87 | +$497.2K |
| Apr 28, 2026 | Behrenbruch ChristianMD & Group CEO · Director | 34,500 | $14.48 | +$499.6K |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Don't check TLX — let it ping you
Watch every insider filing the minute it clears the SEC
The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.
Telix Pharmaceuticals Ltd is outside the 777 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.
Other companies insiders are buying now
Questions
- How much TLX stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 1 Telix Pharmaceuticals Ltd insider made 2 open-market purchases worth $996.7K and no sales. In the four quarters to Jun 30, 2026: 2 purchases ($996.7K) and no sales. The largest purchase was Behrenbruch Christian buying $499.6K on Apr 28, 2026.
- Where does TLX insider trading data come from?
- From the Form 4 filings Telix Pharmaceuticals Ltd's officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.